zenith laboratori inc said receiv food and drug administr approv market cephalexin antibiot generic version eli lilli inc keflex generic drug low cost copi brand name drug have lost patent keflex patent expir april analyst said four generic drug compani includ zenith will have approv market generic keflex this year analyst said keflex lilli second lead drug product with 1986 worldwid sale about 335 mln dlrs 1986 lilli had sale billion dlrs think first year lose it patent sale keflex will drop about 240 mln dlrs from 280 mln dlrs said joe riccardo associ director bear stearn riccardo said lilli would offset loss with sale from humatrop genet engin human growth hormon recent approv for market also said was like lilli would fda market approv this year for prozac drug for treat clinic depress also show promis weight reduct reuter 